ALXO
Alx Oncology Holdings Inc

1,240
Mkt Cap
$64.52M
Volume
281,615.00
52W High
$2.27
52W Low
$0.404
PE Ratio
-0.56
ALXO Fundamentals
Price
$1.13
Prev Close
$1.19
Open
$1.18
50D MA
$1.43
Beta
1.44
Avg. Volume
354,018.63
EPS (Annual)
-$2.58
P/B
1.35
Rev/Employee
$0.00
Loading...
Loading...
News
all
press releases
Short Interest in ALX Oncology Holdings Inc. (NASDAQ:ALXO) Expands By 32.0%
ALX Oncology Holdings Inc. (NASDAQ:ALXO - Get Free Report) saw a large growth in short interest during the month of December. As of December 15th, there was short interest totaling 1,047,613 shares...
MarketBeat·2d ago
News Placeholder
More News
News Placeholder
ALX Oncology (NASDAQ:ALXO) Stock Rating Upgraded by Wall Street Zen
Wall Street Zen raised shares of ALX Oncology from a "sell" rating to a "hold" rating in a research report on Monday...
MarketBeat·10d ago
News Placeholder
ALX Oncology (NASDAQ:ALXO) Lowered to "Sell" Rating by Wall Street Zen
Wall Street Zen downgraded shares of ALX Oncology from a "hold" rating to a "sell" rating in a research report on Sunday...
MarketBeat·18d ago
News Placeholder
ALX Oncology Holdings Inc. (NASDAQ:ALXO) Receives Consensus Rating of "Moderate Buy" from Analysts
ALX Oncology Holdings Inc. (NASDAQ:ALXO - Get Free Report) has received an average rating of "Moderate Buy" from the seven ratings firms that are presently covering the company, MarketBeat.com...
MarketBeat·24d ago
News Placeholder
ALX Oncology (NASDAQ:ALXO) Upgraded by Wall Street Zen to Hold Rating
Wall Street Zen upgraded ALX Oncology from a "sell" rating to a "hold" rating in a report on Saturday...
MarketBeat·26d ago
News Placeholder
ALX Oncology (NASDAQ:ALXO) Stock Price Up 3.8% - Here's Why
ALX Oncology (NASDAQ:ALXO) Trading 3.8% Higher - Still a Buy...
MarketBeat·26d ago
News Placeholder
ALX Oncology (NASDAQ:ALXO) Earns Buy Rating from Analysts at Jefferies Financial Group
Jefferies Financial Group initiated coverage on ALX Oncology in a research report on Thursday. They set a "buy" rating and a $4.00 target price for the company...
MarketBeat·2mo ago
News Placeholder
Cantor Fitzgerald Weighs in on ALX Oncology FY2025 Earnings
ALX Oncology Holdings Inc. (NASDAQ:ALXO - Free Report) - Analysts at Cantor Fitzgerald dropped their FY2025 earnings per share estimates for ALX Oncology in a report issued on Monday, November 10th...
MarketBeat·2mo ago
News Placeholder
ALX Oncology (NASDAQ:ALXO) Issues Quarterly Earnings Results
ALX Oncology (NASDAQ:ALXO - Get Free Report) announced its quarterly earnings results on Friday. The company reported ($0.41) earnings per share (EPS) for the quarter, missing the consensus estimate...
MarketBeat·2mo ago
News Placeholder
Examining the Future: ALX Oncology Holdings's Earnings Outlook
read more...
Benzinga·2mo ago
<
1
2
...
>

Latest ALXO News

View

Advertisement|Remove ads.

Advertisement|Remove ads.